Tocilizumab - CaLiGraph

Property	Value
rdf:type	Genentech brand Hoffmann-La Roche brand owl:NamedIndividual Disease-modifying antirheumatic drug Immunosuppressant Monoclonal antibody Orphan drug Therapeutic monoclonal antibody Drug granted breakthrough therapy designation
rdfs:label	Tocilizumab
owl:sameAs	dbr:Tocilizumab
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Transplant_rejection http://en.wikipedia.org/wiki/Roche http://en.wikipedia.org/wiki/Category:Orphan_drugs http://en.wikipedia.org/wiki/List_of_drugs:_Tj%E2%80%93Tq http://en.wikipedia.org/wiki/List_of_therapeutic_monoclonal_antibodies http://en.wikipedia.org/wiki/Timeline_of_the_COVID-19_pandemic_in_the_United_Kingdom_(July%E2%80%93December_2020) http://en.wikipedia.org/wiki/Ankylosing_spondylitis http://en.wikipedia.org/wiki/Antiarthritics http://en.wikipedia.org/wiki/Category:Disease-modifying_antirheumatic_drugs http://en.wikipedia.org/wiki/Category:Immunosuppressants http://en.wikipedia.org/wiki/Category:Monoclonal_antibodies http://en.wikipedia.org/wiki/Disease-modifying_antirheumatic_drug http://en.wikipedia.org/wiki/Monoclonal_antibody_therapy http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation http://en.wikipedia.org/wiki/Category:Genentech_brands http://en.wikipedia.org/wiki/Category:Hoffmann-La_Roche_brands http://en.wikipedia.org/wiki/RECOVERY_Trial http://en.wikipedia.org/wiki/COVID-19_drug_development
skos:prefLabel	Tocilizumab
skos:altLabel	Actemra Actemra (Hoffmann-La Roche/Chugai) Actemra® tocilizumab
clgo:alternativeName	Actemra, RoActemra
clgo:casNumber	375823-41-9
clgo:chEMBL	1237022
clgo:drugbank	DB06273
clgo:fdaUniiCode	I031V2H011
clgo:kegg	D02596
clgo:medlinePlus	a611004
is clgo:product of	Genentech

About: clgr:Tocilizumab